The intersections of industry with the health research enterprise

dc.contributor.authorAkl, Elie A.
dc.contributor.authorKhamis, Assem M.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentClinical Research Institute
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:53:48Z
dc.date.available2025-01-24T11:53:48Z
dc.date.issued2019
dc.description.abstractThere is increased awareness of the negative impact of large multinational corporations - the 'industry' - on public health. These corporations have established different types of relationships with a number of actors in the field of health research. This Commentary explores the different types of relationships between the industry and the actors of health research, how they intersect with the different research steps, and how these relationships allow the industry to exert influence. The types of relationships discussed consist of funding of research, direct relationships with the actors of research (namely advocacy groups, funding agencies, experts, professional organisations, regulatory agencies and health practitioners), and the influencing research standards. The potentially influenced research steps either precede the research (i.e. the prioritisation of research question), relate to it directly (i.e. its planning, conduct, reporting, dissemination and evaluation), or build on it (i.e. regulatory approval, integration into guidelines and adoption into practice). In conclusion, the industry has successfully fostered relationships with almost every actor of the health research enterprise and is using these relationships to influence the different steps of health research. The degree of influence the industry is having on health research calls for more work on managing the relationships discussed herein. © 2019 The Author(s).
dc.identifier.doihttps://doi.org/10.1186/s12961-019-0457-7
dc.identifier.eid2-s2.0-85066930370
dc.identifier.pmid31142343
dc.identifier.urihttp://hdl.handle.net/10938/31128
dc.language.isoen
dc.publisherBioMed Central Ltd.
dc.relation.ispartofHealth Research Policy and Systems
dc.sourceScopus
dc.subjectFunding
dc.subjectHealth research
dc.subjectIndustry
dc.subjectBiomedical research
dc.subjectCommerce
dc.subjectHealth priorities
dc.subjectHumans
dc.subjectInterinstitutional relations
dc.subjectPublic health
dc.subjectResearch support as topic
dc.subjectStakeholder participation
dc.subjectAdoption
dc.subjectAdvocacy group
dc.subjectArticle
dc.subjectAwareness
dc.subjectHealth practitioner
dc.subjectHuman
dc.subjectMedical research
dc.subjectMedical society
dc.subjectPractice guideline
dc.subjectCommercial phenomena
dc.subjectFinancial management
dc.subjectHealth care planning
dc.subjectPublic relations
dc.subjectStakeholder engagement
dc.titleThe intersections of industry with the health research enterprise
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019-7592.pdf
Size:
1022.78 KB
Format:
Adobe Portable Document Format